The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

 
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.

WIRED Science

Get in-depth coverage of current and future trends in technology, and how they are shaping business,… 

Social links